Starpax Biopharma Inc.

Exited
CIK: 1960682•A8•Tier2

Equity (common or preferred stock) · Audited · Healthcare · SIC 2836

$24M
Qualified
maximum offering price, as qualified
$233K
Reported Sold
1-Z 2025-04-18
6
Filings
across 2 offerings

Equity Classes

TypeClassOutstanding
commonCommon Shares75,500,000

Service Providers

RoleProvider
legalThe Ajax Law Group PLLC
sales commissionNetshares Financial Services LLC

Offerings

File NumberFilingsFirst FiledLast FiledQualifiedCommencedPrice/SecuritySecurities OfferedSecurities SoldQualified SoldOutstandingAggregate OfferingProceeds ReportedSupplementsLast Supplement
024-1214942023-02-092024-09-192023-09-112023-09-11$6.004,000,00021,8594,000,00075,500,000$24M$131K12024-03-26

Reporting & Exit

Filed under the issuer’s Regulation A reporting number

File NumberFormFiledSales CommencedSecurities SoldQualified Sold
24R-008991-Z2025-04-182023-09-1138,7694,000,000

Current Reports

Filing DateFormEventItems
2025-03-121-UDeparture of Officers7
2025-01-101-UChange in Control6
2024-02-081-U/AChange of Auditor4
2024-02-071-UChange of Auditor4
2023-12-261-UDeparture of Officers7
Embarc dashboard

Operations, the balance sheet and cash flows as filed, year by year — the filer's own captions, not a mapped chart of accounts — plus the tagged figures from every Form 1-A family filing, plotted on the dates they were actually reported. EDGAR still has each 1-K; the dashboard lays every year they filed next to it.

  • Every caption as the filer wrote it, across every annual report — not just the latest 1-K
  • Tagged reported figures across every filing — revenue, assets, cash — with a sparkline on the actual filing dates
  • A sparkline on each annual-statement line, so the shape is visible before the figures
  • A revenue series dated to the filings that reported it
  • A filing history that says what each document contributed, not only that it exists
  • Follow it, and see it change on your watchlist
Open in the dashboard
External link: SEC Filings